In order to succeed in translating the scientific model of genetic testing and pharmacogenomics into clinical practice, empowering health workers with the right knowledge and […]
Continue readingCategory: Peptides
The Road so Far in Colorectal Cancer Pharmacogenomics: Are We Closer to Individualised Treatment?
In the past few decades, the survival rate in colorectal cancer has increased rapidly due to pharmacological treatment. However, many patients finally develop a detrimental […]
Continue reading
Pharmacogenomic Biomarkers and Their Applications in Psychiatry
Realizing the promise of precision medical in psychiatry is an effort that should be praised and beneficial, because it must significantly reduce morbidity and mortality […]
Continue reading
Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis
Polycystic Ovary Syndrome (PCOS) is a heterogeneous endocrine disorder characterized by hyperandrogenism, ovulation dysfunction, and polycystic ovaries. Epidemiological findings reveal that women with PCOS tend […]
Continue reading
Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression
We evaluate the clinical validity of the pharmacogenomic test combination and the implementation guidelines for single clinical pharmacogenetics (CPIC) on patient outcomes and blood levels […]
Continue reading
Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis
One target drug for plaque psoriasis treatment is apremilast, which is a phosphodiesterase 4 (PDE4) inhibitor selective. In this study, 34 patients with moderate and […]
Continue reading